Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Free Cash Flow Generation Index

Latest as of September 2025: 0.49x

Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Free Cash Flow Generation Index of 0.49x as of September 2025. Free cash flow of CN¥1.76 Million represents 0% of operating cash flow (CN¥3.56 Million). See working capital position of Jiangsu Aidea Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.49x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥1.76 Million
CNY

Operating Cash Flow

CN¥3.56 Million
CNY

Capital Expenditures

CN¥1.81 Million
CNY

Jiangsu Aidea Pharmaceutical Co Ltd Free Cash Flow Generation Index (2016–2020)

Historical FCF Generation Index trend for Jiangsu Aidea Pharmaceutical Co Ltd across 3 annual periods. Explore debt repayment capacity of Jiangsu Aidea Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)

Year-by-year Free Cash Flow Generation Index for Jiangsu Aidea Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jiangsu Aidea Pharmaceutical Co Ltd market cap and net worth.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2020 0.24x CN¥13.74 Million CN¥56.17 Million CN¥42.43 Million ▼ -39.4%
2019 0.40x CN¥22.70 Million CN¥56.20 Million CN¥33.50 Million ▲ +131.8%
2016 -1.27x CN¥-39.72 Million CN¥31.29 Million CN¥71.01 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).